Cite
Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.
MLA
Sato, Sho, et al. “Pre-Operative Evaluation of Circulating KL-6 Levels as a Biomarker for Epithelial Ovarian Carcinoma and Its Correlation with Tumor MUC1 Expression.” Oncology Letters, vol. 14, no. 1, July 2017, pp. 776–86. EBSCOhost, https://doi.org/10.3892/ol.2017.6254.
APA
Sato, S., Kato, T., Abe, K., Hanaoka, T., Yano, Y., Kurosaki, A., Yasuda, M., Sekino, T., Fujiwara, K., & Hasegawa, K. (2017). Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression. Oncology Letters, 14(1), 776–786. https://doi.org/10.3892/ol.2017.6254
Chicago
Sato, Sho, Tomomi Kato, Kenji Abe, Tatsuya Hanaoka, Yuri Yano, Akira Kurosaki, Masanori Yasuda, Tetsuo Sekino, Keiichi Fujiwara, and Kosei Hasegawa. 2017. “Pre-Operative Evaluation of Circulating KL-6 Levels as a Biomarker for Epithelial Ovarian Carcinoma and Its Correlation with Tumor MUC1 Expression.” Oncology Letters 14 (1): 776–86. doi:10.3892/ol.2017.6254.